MLchartDataset catalogue

Pegasys

Term · Oncology and biomedicine · MLC-T-ONC-006447

A drug used to treat hepatitis C infections. It is also being studied in the treatment and prevention of cancer. It is a cytokine that is modified in the laboratory. It is a type of biological response modifier. Also called peginterferon alfa-2a.

Table 1. Record
IdentifierMLC-T-ONC-006447
FieldOncology and biomedicine
Synonymspeginterferon alfa-2a
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-006447",
  "term": "Pegasys",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat hepatitis C infections. It is also being studied in the treatment and prevention of cancer. It is a cytokine that is modified in the laboratory. It is a type of biological response modifier. Also called peginterferon alfa-2a.",
  "synonyms": [
    "peginterferon alfa-2a"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/pegasys/"
}

Record 12,834 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.